Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

CPMP recommends approval of Busulfex in Europe

March 27, 2003

Enrollment under way in pivotal trial of T-67 in hepatocellular carcinoma

March 27, 2003

Italian researchers identify novel antitumor taxanes

March 27, 2003

NIH licensing a class of gp100 cancer antigens

March 26, 2003

GTI-2040 awarded orphan drug status for renal cell cancer

March 26, 2003

Methods of prophylaxis and treatment of HER-2/neu tumors

March 25, 2003

Novel GnRH antagonists discovered by Neurocrine scientists

March 25, 2003

Pharma Mar identifies new antitumor ecteinascidin derivatives

March 25, 2003

Combination therapy containing zosuquidar reverses multidrug resistance in AML

March 25, 2003

Long-lasting antitumor activity reported for Bexxar in refractory B-cell lymphoma

March 25, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...